Director sold
~$44KReported value · 275 sh @ $161.00
A board member of Repligen sold $44K of Repligen shares. Nobody planned it ahead of time.
Traded Dec 4, 2025 · Filed Dec 9, 2025
Not classified as an open-market trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
other
Code J — not an open-market trade
None found in footnotes
Only flagged when a footnote says so; never inferred
A board member of Repligen sold $44K of Repligen shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.